Campus News

Joint biomedical research program awards grants at UGA, Georgia Tech

The University of Georgia and the Georgia Institute of Technology have awarded four inter-institutional research teams a total of $200,000 to conduct biomedical research and expand collaborative research between the two universities.

The Georgia Tech-UGA Biomedical Research Program, administered by the Petit Institute for Bioengineering and Bioscience at Georgia Tech and the Biomedical and Health Sciences Institute at UGA, will provide each research team with $50,000 annually for a period of up to two years.

“The intent of the program is to leverage the different strengths of Georgia Tech and UGA and provide the opportunity for faculty from the two institutions to be successful in seeking external grants that will fund joint research,” says Harry Dailey, BHSI director.

Applications were reviewed by a joint committee of biomedical scientists from both institutions and evaluated on the basis of scientific merit, potential for external funding and value toward enhancing biomedical research collaborations between the two institutions.

Richard Dluhy, a professor of chemistry at UGA, and Lawrence Bottomley, a professor of chemistry and biochemistry at Georgia Tech, will combine nanotechnology with surface-enhanced raman-nanoforce microscopy to develop a biosensor capable of direct, rapid and sensitive detection of infectious viral agents, particularly those which cause respiratory illnesses.

Nancy Manley, an associate professor of genetics at UGA, and J. Todd Streelman, an assistant professor in biology at Georgia Tech, will work to identify the molecules and genetic pathways necessary for jaw development, using the cichlid fish as a model system. Roughly 14 percent of known human inherited conditions involve craniofacial ­abnormality.

Steve Stice, a professor of animal and dairy science at UGA, and Todd McDevitt, a professor in biomedical engineering at Georgia Tech, will design in-vitro microenvironments capable of controlling human embryonic stem cell behavior. They hope eventually to be able to describe the cell signaling pathways involved in maintaining undifferentiated human embryonic stem cells.

Walter Schmidt, an assistant professor of biochemistry and molecular biology at UGA, and Yury Chernoff, an associate professor of biology at Georgia Tech, will study the formation and dispersal of amyloids, fiber-like protein aggregates characteristic of prion diseases and of such diseases as Alzheimer’s, Huntington’s and Parkinson’s.